Takeda Pharmaceutical Co. Ltd. (TKDG.DE) and Metabolon Initiate Research Collaboration to Discover Novel Targets and Biomarkers

4/17/2012 9:56:22 AM

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Metabolon, Inc., a diagnostics and services company offering the industry’s leading biochemical profiling technology announces that Metabolon and Takeda Pharmaceutical Company Limited (TSE: 4502), a global pharmaceutical company, have formed a multiyear research alliance that will focus on discovering therapeutic targets and biomarkers.

Read at BioSpace.com

Read Article at

Related Companies

News Categories

• BioSpace.com

• Metabolon

• Takeda Pharmaceutical Co. Ltd.

• Biotech/Pharma - Alliances

• Diagnostics

• Medical Dev. & Diag. - Alliances